Wellington Shields & Co., LLC Gilead Sciences, Inc. Transaction History

Wellington Shields & Co., LLC

$303 Million
Q2 2024

A detailed history of Wellington Shields & Co., LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Wellington Shields & Co., LLC holds 6,269 shares of GILD stock, worth $524,151. This represents 0.14% of its overall portfolio holdings.

Number of Shares

6,269

Previous 6,330 0.96%

Holding current value

$524,151

Previous $463,000 7.13%

% of portfolio

0.14%

Previous 0.16%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$63.15 - $72.88 $3,852 - $4,445	-61 Reduced 0.96%	6,269 $430,000
Q1 2024 May 23, 2024	SELL	$71.58 - $87.29 $49,103 - $59,880	-686 Reduced 9.78%	6,330 $463,000
Q1 2024 May 23, 2024	BUY	$71.58 - $87.29 $49,103 - $59,880	686 Added 10.84%	7,016 $513,000
Q1 2024 May 03, 2024	SELL	$71.58 - $87.29 $49,103 - $59,880	-686 Reduced 9.78%	6,330 $463,000
Q4 2023 Feb 09, 2024	BUY	$73.27 - $83.09 $1,318 - $1,495	18 Added 0.26%	7,016 $568,000
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $66,546 - $72,603	-900 Reduced 11.4%	6,998 $524,000
Q2 2023 Aug 11, 2023	SELL	$76.01 - $86.7 $15,202 - $17,340	-200 Reduced 2.47%	7,898 $608,000
Q1 2023 May 11, 2023	SELL	$77.31 - $88.08 $38,655 - $44,040	-500 Reduced 5.82%	8,098 $671,000
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $50,977 - $73,186	-818 Reduced 8.69%	8,598 $738,000
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $8,871 - $10,133	149 Added 1.61%	9,416 $581,000
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $2,886 - $3,250	-50 Reduced 0.54%	9,267 $573,000
Q1 2022 May 09, 2022	BUY	$57.92 - $72.58 $1,679 - $2,104	29 Added 0.31%	9,317 $554,000
Q4 2021 Feb 15, 2022	SELL	$64.88 - $73.64 $65,074 - $73,860	-1,003 Reduced 9.75%	9,288 $674,000
Q3 2021 Nov 10, 2021	BUY	$67.69 - $73.03 $133,484 - $144,015	1,972 Added 23.7%	10,291 $719,000
Q2 2021 Aug 12, 2021	BUY	$63.47 - $69.35 $10,472 - $11,442	165 Added 2.02%	8,319 $573,000
Q1 2021 May 12, 2021	BUY	$60.0 - $68.46 $40,800 - $46,552	680 Added 9.1%	8,154 $527,000
Q4 2020 Feb 09, 2021	SELL	$56.65 - $64.55 $69,736 - $79,461	-1,231 Reduced 14.14%	7,474 $435,000
Q3 2020 Nov 10, 2020	BUY	$62.1 - $78.08 $87,250 - $109,702	1,405 Added 19.25%	8,705 $550,000
Q2 2020 Aug 05, 2020	SELL	$72.34 - $84.0 $256,807 - $298,200	-3,550 Reduced 32.72%	7,300 $562,000
Q1 2020 May 07, 2020	SELL	$62.63 - $80.22 $100,208 - $128,352	-1,600 Reduced 12.85%	10,850 $811,000
Q4 2019 Feb 11, 2020	BUY	$61.62 - $67.78 $767,169 - $843,861	12,450 New	12,450 $809,000
Q3 2019 Nov 05, 2019	SELL	$62.51 - $69.0 $847,010 - $934,950	-13,550 Closed	0 $0
Q2 2019 Aug 08, 2019	BUY	$61.87 - $69.38 $52,589 - $58,972	850 Added 6.69%	13,550 $915,000
Q1 2019 May 10, 2019	BUY	$62.53 - $70.05 $150,072 - $168,120	2,400 Added 23.3%	12,700 $826,000
Q4 2018 Feb 11, 2019	BUY	$60.54 - $79.0 $623,562 - $813,700	10,300 New	10,300 $644,000

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Shields & Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Shields & Co., LLC with notifications on news.

Account

Wellington Shields & Co., LLC Gilead Sciences, Inc. Transaction History